Re: Randomized Trial for 3 Maintenance Regimens (TAC/SRL vs. TAC/MMF vs CSA/SRL) with Low-Dose Corticosteroids in Primary Kidney Transplantation: 18-Year Results

被引：0
|
作者：
Goldfarb, David A.
机构：
来源：
JOURNAL OF UROLOGY | 2021年 / 206卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：149 / 149
页数：1
相关论文
共 15 条
  • [1] Randomized trial of 3 maintenance regimens (TAC/SRL vs. TAC/MMF vs. CSA/SRL) with low-dose corticosteroids in primary kidney transplantation: 18-year results
    Ciancio, Gaetano
    Gaynor, Jeffrey J.
    Guerra, Giselle
    Roth, David
    Chen, Linda
    Kupin, Warren
    Mattiazzi, Adela
    Ortigosa-Goggins, Mariella
    Moni, Lissett
    Burke, George W., III
    CLINICAL TRANSPLANTATION, 2020, 34 (12)
  • [2] Randomized trial of 3 maintenance regimens (TAC/SRL vs. TAC/MMF vs. CSA/SRL) with low-dose corticosteroids in primary kidney transplantation: 18-year results (vol 34, e14123, 2020)
    Ciancio, G.
    Gaynor, J. J.
    Guerra, G.
    CLINICAL TRANSPLANTATION, 2021, 35 (12)
  • [3] Prospective Randomized Trial of Sirolimus (SRL) and Mycophenolate Mofetil (MMF) vs. Tacrolimus (TAC) plus MMF Therapy Following Thymoglobulin (THY) Induction with Rapid Steroid Taper (RST) in Primary Kidney Transplantation (KTX).
    Gonwa, Thomas A.
    Heilman, Raymond L.
    Wadei, Hani M.
    Reddy, Kunam S.
    Mai, Martin L.
    Mazur, Marek
    Ahsan, Nasimul
    Younan, Kerri
    Mulligan, David C.
    Grewal, Hani
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 341 - 341
  • [4] Tacrolimus/sirolimus (TAC/SRL) vs tacrolimus/mycophenolate (TAC/MPA) in kidney transplantation: Comparable 3-year graft and patient survival in recent era
    Gralla, Jane
    Wiseman, Alexander C.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 256 - 256
  • [5] Influence of Immunosuppression, Donor Age, and Rejection on Chronic Banff Scores of 1 Year Protocol Biopsies in a Prospective Randomized Trial of Tacrolimus (TAC) plus Mycophenolate Mofetil (MMF) vs. Sirolimus (SRL) plus MMF Therapy Following Thymoglobulib (THY) Induction with Rapid Steroid Taper (RST).
    Gonwa, Thomas A.
    Heilman, Raymond L.
    Younan, Kerri
    Cortese, Cherise
    Geiger, Xochi
    Wadei, Hani M.
    Reddy, Kunam S.
    Mai, Martin L.
    Mazur, Marek
    Ahsan, Nasim
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 259 - 259
  • [6] A randomized, open-label study to compare the efficacy and safety of two different sirolimus (SRL) regimens with tacrolimus (TAC) plus mycophenolate mofetil (MMF) in de novo renal allograft recipients: Preliminary 2-year efficacy results from the ORION trial
    Flechner, Stuart M.
    Cockfield, Sandra
    Grinyo, Josep
    Russ, Graeme
    Wissing, K. Martin
    Legendre, Christophe
    Copley, J. Brian
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 254 - 254
  • [7] A randomized, open-label study to compare the safety and efficacy of two different sirolimus (SRL) regimens with tacrolimus (TAC) plus mycophenolate mofetil (MMF) in De Novo renal allograft recipients:: Preliminary 2-year safety results from the ORION trial
    Flechner, Stuart M.
    Cockfield, Sandra
    Grinyo, Josep
    Russ, Graeme
    Wissing, K. Martin
    Legendre, Christophe
    Copley, J. Brian
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 582 - 582
  • [8] CORRETA trial (CORticosteroid REduction with TAcrolimus):: A prospective Brazilian multicenter, randomized trial of early steroid reduction vs. regular steroid dosage maintenance on a tacrolimus (TAC-Prograf®) and mycophenolate mofetil (MMF) immunosuppression (IS) regimen in kidney transplant.
    Garcia, Valter D.
    Carvalho, Deise B. M.
    Goncalves, Renato T.
    Cavalcanti, Ray L.
    Campos, Henry H.
    Abbud-Filho, Mario
    Lobao-Neto, Abner A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 593 - 593
  • [9] Comparison of Once-Daily and Twice-Daily Low-Dose Tacrolimus in Living Related Kidney Transplantation -Prospective Trial of Once-Daily vs. Twice-Daily Tac-3 Years Second Report.
    Tsuchiya, T.
    Nozaki, T.
    Inui, M.
    Shimizu, T.
    Kazuya, O.
    Ishida, H.
    Tanabe, K.
    TRANSPLANTATION, 2014, 98 : 584 - 584
  • [10] Comparison of Once-Daily and Twice-Daily Low-Dose Tacrolimus in Living Related Kidney Transplantation -Prospective Trial of Once-Daily vs. Twice-Daily Tac-3 Years Second Report.
    Tsuchiya, T.
    Nozaki, T.
    Inui, M.
    Shimizu, T.
    Kazuya, O.
    Ishida, H.
    Tanabe, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 584 - 584
12